Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-246-6 | CAS number: 68201-95-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
No bioaccumulation potential.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Direct Red 253 (DR253) is a dark brown/purple organic solid, marketed/used in a non-solid or granular form.
DR253 is not toxic/harmful for short-term exposures and it is not skin/eye irritating. It is not able to cause an allergic skin reaction. No CMR activity has been never been reported in literature and has not be observed in specific experiments performed. Therefore, mechanisms of bioactivation leading to adverse effects are not expected to occur.
Specific studies or specific literature data on toxicokinetics and metabolism are not available, thus available information about the substance has been taken into account, avoiding further tests.
Because of the molecular size and the hydrophilic character of DR253, dermal absorption is expected to be negligible. The skin metabolites simulation proposes possible reduction/oxidation reactions, mainly involving azo bonds and naphthalene ring, break of the azo bond, possibly accompanied by the aniline sulphate removal and removal of phenylenediamine.
Based on the available information, a substance acute dermal toxicity potential is not suspected. Furthermore, the substance gave negative results in skin sensitisation potential investigation, thus it is considered as not able to cause an allergic response in susceptible individuals, after exposure via the skin.
Because of the physical state and the trade forms of the substance under registration, inhalation is not an appropriate route of exposure; furthermore, considering the molecular size and the hydrophilic character of DR253, dermal absorption is expected to be negligible.
The high water solubility suggests that DR253 is a hydrophilic substance, thus it is expected that only a small rate of substance as such could be absorbed by oral route.
No abnormalities were recorded in the acute toxicity studies available, by oral route.
During the subacute oral, the treatment did not produce changes detected in health condition control, except coloured faeces; the extension of substance as such elimination is not know. Findings observed in both sexes were considered to be of no toxicological significance. No significant changes related to test substance administration were recorded up to the highest tested dose of 1000 mg/kg bw/day.
DR253 is a di-sulphonated substance; the sulphonation degree contributes to increased solubility and to increased detoxification.
Because the chemical structure, a potential azo bond cleavage has been suspected on the basis of general mechanism described in literature and based on the in silico estimation. From this point of view, a critical aspect is related to the possible formation of aromatic amines, in particular aniline release, which is a known CMR. The genetic toxicity potential of DR253 has been deeply investigated by in vitro and in vivo test systems, assaying mutagenicity and clastogenicity, with and without metabolic activation. No signs of genetic toxicity potential have been reported and it has been concluded that the substance can be considered as non-mutagenic/clastogenic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.